Overview
Study on the Feasibility of Community Doctors Guided by Specialists to Use Basic Insulin
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2022-03-31
2022-03-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
At present, one of the reasons for the low blood sugar control rate in China is related to the late use of basic insulin and insufficient dose adjustment. If the community hospital can actively treat the diabetic patients who need to use insulin and adjust the dose in time, it will certainly improve the blood sugar control rate. However, at present, community doctors basically do not take the initiative to start insulin treatment, but only passively use insulin that has been prescribed by specialists, and there is a lack of ability to adjust the dose of insulin and treatment inertia. Therefore, it is very necessary for community doctors to receive guidance from endocrine specialists to improve their ability to use insulin. This study intends to carry out a study of endocrine specialists guiding community doctors to use basic insulin in the treatment of adult type 2 diabetes in Shenzhen Community Hospital. Through this study to understand whether the effectiveness and safety of community doctors actively using basic insulin therapy under the guidance of specialists can reach the level of specialists.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Shenzhen Second People's HospitalTreatments:
Insulin
Insulin Glargine
Criteria
Inclusion Criteria:1. Diagnosis of T2DM (WHO1999 diabetes diagnostic criteria);
2. The age is ≥ 18 and ≤ 65 years old;
3. Continuous use of 2 or more oral hypoglycemic drugs for 1 month but HbA1c ≥ 8.0% and
FPG ≥ 10mmol/L.
Exclusion Criteria:
1. Severe abnormal liver and kidney function and cardiac insufficiency;
2. Complicated with all kinds of acute and chronic infection or coronary heart disease,
kidney disease, connective tissue disease, tumor, stroke and so on;
3. There are acute metabolic disorders caused by stress and diseases affecting glucose
metabolism, such as pheochromocytoma, acromegaly, Cushing syndrome, hyperthyroidism
and so on.
4. Acute complications of diabetes, such as diabetic ketoacidosis, hyperglycemic
hyperosmotic coma or lactic acidosis, etc.